Hypervision Surgical
Founded 2021 · 28 employees on LinkedIn · 13 known investors
Hypervision Surgical develops an intraoperative hyperspectral imaging system that uses AI to provide real-time, contrast-free tissue characterisation during surgery. The technology is designed to help surgeons visualise and assess tissue properties, improving surgical precision and patient safety.
Investors · 13
Heal CapitalBerlin · $1M – $5M
Heran PartnersAntwerp
LifeX VenturesSan Franciscovia Inaki Berenguer · inferred
Meridian Health VenturesLondon
SonorcapParisvia Frederic Halley · inferred
Angelini Venturesreported · 2 sourcesRome
redalpinereported · 2 sourcesZug · $108K – $2.2M
ZEISS VenturesreportedOberkochen
Also in the syndicate · 5
DaycrestHEARN PartnersIP GroupRedalphineSAGES Ingenuity
Funding
SEC filings, press & company announcements- Undisclosed amountSeries AApr 2026 · 4 sources
Heal Capital (lead), Angelini Ventures, Daycrest, HEARN Partners, HERAN Partners, IP Group, LifeX Ventures, Redalphine, Redalpine, SAGES Ingenuity, ZEISS Ventures
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Hypervision Surgical do?
- Hypervision Surgical develops an intraoperative hyperspectral imaging system that uses AI to provide real-time, contrast-free tissue characterisation during surgery. The technology is designed to help surgeons visualise and assess tissue properties, improving surgical precision and patient safety.
- Who are Hypervision Surgical's investors?
- Hypervision Surgical's investors include Heal Capital, Heran Partners, LifeX Ventures, Meridian Health Ventures, Sonorcap, Angelini Ventures, redalpine, ZEISS Ventures.